LLY | Eli Lilly
297.01 -6.24 (-2.06%)
LLY Price Profile
Open
$300.16
CLOSE
$297.01
DAY RANGE
296.87 - 301.66
52 WEEK RANGE
217.00 - 324.08
MARKET CAP
227.53B
Trading volume
786.9K
Prev. Close
303.25
50 Day MA
257.89
Shares Outstanding
956.59M
Public Float
904.82M
Average Volume
3.35M
Beta
0.36
PEG Ratio
5.20
Shares Shorted
6.19M
% OF SHARES SHORTED
0.78%
Short Ratio
1.80
1 Year Performance
0.00%
Diluted EPS (TTM)
6.55
Q Revenue Growth
0.18
Ebitda
9.66B
Gross Profit (TTM)
19.06B
Total Cash (MRQ)
3.85B
Total Debt (MRQ)
17.14B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Eli Lilly (LLY) company profile
Eli Lilly and Company (NYSE:LLY) is a drug manufacturing company for humans and animals. The company engages in discovering, developing, manufacturing, and selling pharmaceutical products. Its products include Diabetes and other endocrinology products like Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. The company manufactures and sells its products through facilities in the United States, Puerto Rico, and eight other countries with production in about approximately 120 countries.
